Comments
Loading...

Enanta Pharma

ENTANASDAQ
Logo brought to you by Benzinga Data
$11.39
-0.26-2.23%
At Close: -
$11.43
0.040.35%
After Hours: 6:06 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$116.00
Lowest Price Target1
$10.00
Consensus Price Target1
$48.92

Enanta Pharma (NASDAQ:ENTA) Stock, Analyst Ratings, Price Targets, Forecasts

Enanta Pharmaceuticals Inc has a consensus price target of $48.92 based on the ratings of 12 analysts. The high is $116 issued by JMP Securities on November 23, 2021. The low is $10 issued by JP Morgan on August 6, 2024. The 3 most-recent analyst ratings were released by JP Morgan, HC Wainwright & Co., and HC Wainwright & Co. on August 6, 2024, August 6, 2024, and May 7, 2024, respectively. With an average price target of $21.33 between JP Morgan, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 86.64% upside for Enanta Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
HC Wainwright & Co.
JMP Securities
Oppenheimer
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Enanta Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Enanta Pharma (ENTA) stock?

A

The latest price target for Enanta Pharma (NASDAQ:ENTA) was reported by JP Morgan on August 6, 2024. The analyst firm set a price target for $10.00 expecting ENTA to fall to within 12 months (a possible -12.51% downside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Enanta Pharma (ENTA)?

A

The latest analyst rating for Enanta Pharma (NASDAQ:ENTA) was provided by JP Morgan, and Enanta Pharma maintained their underweight rating.

Q

When was the last upgrade for Enanta Pharma (ENTA)?

A

The last upgrade for Enanta Pharmaceuticals Inc happened on July 6, 2022 when Evercore ISI Group raised their price target to $62. Evercore ISI Group previously had an in-line for Enanta Pharmaceuticals Inc.

Q

When was the last downgrade for Enanta Pharma (ENTA)?

A

The last downgrade for Enanta Pharmaceuticals Inc happened on August 8, 2023 when Jefferies changed their price target from $49 to $18 for Enanta Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Enanta Pharma (ENTA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enanta Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enanta Pharma was filed on August 6, 2024 so you should expect the next rating to be made available sometime around August 6, 2025.

Q

Is the Analyst Rating Enanta Pharma (ENTA) correct?

A

While ratings are subjective and will change, the latest Enanta Pharma (ENTA) rating was a maintained with a price target of $11.00 to $10.00. The current price Enanta Pharma (ENTA) is trading at is $11.43, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch